Secondary Prevention Flashcards

1
Q

Define screening

A

Screening is the process of identifying apparently health people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What 3 categories of things can screening lead to the early detection of?

A
  • disease
  • pre-cursor
  • susceptibility to disease in individuals with no signs or symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are 4 methods of screening?

A

questionnaire
examination
lab tests imaging
imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe what is meant by:

  • false postive
  • false negative
A

False postitive = test result is positive, when person does not have the disease
False negative = test result is negative, when person does have the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe what is meant by a sensitive test

When is the test more useful?

A

The threshold is closer to the no disease curve.
This reduces the incidence of false negatives.
The test is more useful when the result is negative as you can be almost certain that the patient does not have the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is sensitivity calculated from a table?

A

a/a+c
Vertical!
The number of true positive divided by the total number with the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe what is meant by a specific test

When is the test more useful?

A

The threshold for the test is closer to the disease curve.
This reduces the incidence of false positives
This is useful if the test is positive e.g. in down syndrome, as so much rides on a positive test result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is specificity calculated from a table?

A

b/b+d
Vertical!
The number of true negatives divided by the total number with no disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the positive predictive value?
What is the negative predictive value?
How are they calculated?

A

PPV = if you test positive, how likely is it that you really have the disease
a/a+b HORIZONTAL
NPV = if you test negative, how likely is it that you really don’t have the disease
d/c+d HORIZONTAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do you calculate prevalence from the predictive values?

A

a+c / a+b+c+d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Screening in low risk populations results in high rates of ………. …………. . How does this impact who we screen?

A

false positives
This is why we only screen high risk populations as oppose to whole populations. To reduce the incidence of false positives, where subsequent diagnosis and treatment could have negative consequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the relationship between predictive value and prevalence and how this impacts the populations we target.

A

PPV starts low and increases as prevalence increases.
NPV starts high and then drops off at high prevalence.
NPV remains high for most conditions so still target high risk populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differentiate between screening tests and screening programmes.

A

Screening test is the individual test that says negative or positive. However this is of little use to the patient.

Screening programmes include the test, but consider population at risk, screening interval, options for diagnosis and treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do screening programmes involve?

A
  • Systematic invitation of an agreed population of apparently healthy individuals to undertake a screening test.
  • Further investigation, assessment and diagnosis of those screening positive.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Everyone of the following outcomes has a set of risks. The benefits must outweigh the harm caused by a screening programme.
Explain.

A

True positive = NNS to benefit, ‘labelling’
True negative = costs and hazards of screening
False positive = costs/hazards of further tests, anxiety, fear of future screening
False negative = false reassurance, disregards symptoms and delays intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A condition is only worth screening for if we understand the natural history.
What is included in the natural history of disease?

A

Biological onset
Early diagnosis possible
Usual clinical diagnosis
Outcome –> recovery/disability/death

17
Q

What is needed in order for screening to be worth it for a particular disease?

A
  • pre-clinical detectable period
  • test that can be applied
  • treatment that will alter outcome
18
Q

Who oversees screening programmes in the UK?

A

National Screening Committee

  • advises ministers on screening policy
  • latest research evidence, MDT groups, patient and service users
  • assess proposed new programmes against criteria to ensure the do more good than harm at reasonable cost
19
Q

What are the general criteria used by the NSC?

  • condition/knowldege of disease
  • treatment
  • programme
  • test
A

The condition/knowledge of the disease
- impornat, has latent phase, natural history, primary prevention implemented
The treatment
- effective treatment, policy on who to treat, adequate facilities
The programme
- RCT evidence of effectiveness, Information understandable by those screened, clinically/socially/ethically acceptable, benefits>harms, value for money
The Test
- suitable, agreed cut-offs, agreed policy for test +ve

20
Q

If compare outcomes (e.g. survival time) in patients identified by screening to those identified clinically, the following three biases can occur:

A
  • volunteer bias
  • lead time bias
  • length bias
21
Q

Describe how volunteer bias can occur

A

Those screened may differ from those not screened. This is most important when coverage is low. For example, those that come to a screening may have other healthy behaviours that may contribute to a better outcome

22
Q

What is lead time bias?

A

Time by which diagnosis is advanced because of screening –> apparent increase survival

23
Q

What is length time bias?

A

Those with long pre-clinical phase more likely o be detected by screening and usually have better prognosis (less aggressive disease)

24
Q

Describe some factors influency screening policy.

A

Media, famous faces put on screening campaigns